E-LIB Suche - Ergebnisse für: Medinger, Michael

1

Allogeneic haematopoietic cell transplantation for chronic ..:

Heim, Dominik ; Baldomero, Helen ; Medinger, Michael...
Swiss Medical Weekly. 154 (2024) 5 - p. 3754 , 2024

2

Pharmacokinetic Modeling and Simulation with Pharmacogeneti..:

Ben Hassine, Khalil ; Seydoux, Claire ; Khier, Sonia...
Transplantation and Cellular Therapy. 30 (2024) 3 - p. 332.e1-332.e15 , 2024

Link: https://doi.org/10.1016/..

3

Mocravimod, a S1P receptor modulator, increases T cell coun..:

Dertschnig, Simone ; Passweg, Jakob ; Bucher, Christoph..
Cellular Immunology. 388-389 (2023) - p. 104719 , 2023

Link: https://doi.org/10.1016/..

4

P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS..:

Medinger, Michael ; Passweg, Jakob ; Bucher, Christoph...
HemaSphere. 7 (2023) S3 - p. e06838fa , 2023

Link: https://doi.org/10.1097/..

5

Effect of pharmacokinetics and pharmacogenomics in adults w..:

Seydoux, Claire ; Uppugunduri, Chakradhara Rao Satyanarayana ; Medinger, Michael...
Bone Marrow Transplantation. 58 (2023) 7 - p. 811-816 , 2023

Link: https://doi.org/10.1038/..

6

Characterization of engraftment dynamics in myelofibrosis a..:

Jungius, Sarah ; Adam, Franziska C. ; Grosheintz, Kerstin...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Mo..:

Dertschnig, Simone ; Gergely, Peter ; Finke, Jürgen...
Transplantation and Cellular Therapy. 29 (2023) 1 - p. 41.e1-41.e9 , 2023

Link: https://doi.org/10.1016/..

8

Epidemiology, outcomes and risk factors for recurrence of C..:

Ragozzino, Silvio ; Mueller, Nicolas J. ; Neofytos, Dionysios...
Bone Marrow Transplantation. 59 (2023) 2 - p. 278-281 , 2023

Link: https://doi.org/10.1038/..

9

Correction: Effect of pharmacokinetics and pharmacogenomics..:

Seydoux, Claire ; Uppugunduri, Chakradhara Rao Satyanarayana ; Medinger, Michael...
Bone Marrow Transplantation. 59 (2023) 2 - p. 294-294 , 2023

Link: https://doi.org/10.1038/..

10

External Validation of the Revised Pretransplant Assessment..:

Fattinger, Nicolas ; Roth, Jan A. ; Baldomero, Helen...
HemaSphere. 6 (2022) 4 - p. e704 , 2022

Link: https://doi.org/10.1097/..

11

Allogeneic hematopoietic stem cell transplantation in non‐H..:

Rebmann, Ekaterina ; Nabergoj, Mitja ; Grandjean, Bastien...
eJHaem. 4 (2022) 1 - p. 258-261 , 2022

Link: https://doi.org/10.1002/..

12

Blinatumomab in Relapsed/Refractory Burkitt Lymphoma:

Bohler, Jeanne ; Bacher, Ulrike ; Banz, Yara...
Cancers. 15 (2022) 1 - p. 44 , 2022

Link: https://doi.org/10.3390/..

13

Impact of busulfan pharmacokinetics on outcome in adult pat..:

Seydoux, Claire ; Battegay, Raphael ; Halter, Joerg...
Bone Marrow Transplantation. 57 (2022) 6 - p. 903-910 , 2022

Link: https://doi.org/10.1038/..

14

Low Incidence of hepatic sinusoidal obstruction syndrome/ve..:

Stutz, Lina ; Halter, Jörg P. ; Heim, Dominik..
Bone Marrow Transplantation. 57 (2022) 3 - p. 391-398 , 2022

Link: https://doi.org/10.1038/..

15

Optimized cyclosporine starting dose may reduce risk of acu..:

Héritier, Jérémie ; Medinger, Michael ; Heim, Dominik...
Bone Marrow Transplantation. 57 (2022) 4 - p. 613-619 , 2022

Link: https://doi.org/10.1038/..